PLUS THERAPEUTICS, Inc. PSTV shares are trading higher on Wednesday. The stock continues to gain after reporting third-quarter financial results on Tuesday.
What To Know: Plus Therapeutics released its third-quarter earnings report after the close of the market Tuesday. The company reported quarterly losses of $1.00 per share, above the analyst consensus estimate of losses of $1.12 per share. The figure represents a 64.91% increase over losses of $2.85 per share from the same period last year
Quarterly sales came in at $1.24 million, missing the analyst consensus estimate of $1.29 million, a 1,600% increase over sales of $73,000 from the same period last year.
Also on Tuesday, the company announced a share repurchase program to purchase up to $500,000 of common stock as well.
Related Link: Pfizer Analysts Cut Their Forecasts Following Q3 Results
PSTV Price Action: Shares of PSTV were up 5.08% at $1.28 at the time of publication, according to Benzinga Pro.
Image by Michal Jarmoluk from Pixabay
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
